SEC Form 3 · accession 0001209191-16-119622
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert D. Dyrness
Director
Period of report
May 12, 2016
Accepted (ET)
May 12, 2016 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2,F3 | holding | — | — | — | 7,246 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Granted pursuant to the Issuer's 2015 Equity Incentive Plan.
- F2Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of the Issuer's common stock.
- F3The RSUs are subject to, and to vest must satisfy, both (a) performance-based vesting restrictions (the RSUs will satisfy the performance-based vesting restrictions upon the first to occur of (x) a change of control as defined in the award agreement and (y) the expiration of the 6 month lock-up period following the Issuer's initial public offering, subject to continued service through such event) and (b) time-based vesting restrictions (33.33% of the RSUs will satisfy the time-based vesting restrictions on each of the first, second and third anniversaries of December 11, 2015, subject to continued service through such dates). In addition, 100% of the RSUs will satisfy the time-based vesting restrictions upon the occurrence of a change of control, subject to continued service through such event.